Afghanistan vs Yemen: Antiretroviral therapy coverage for PMTCT
Afghanistan
14.0%
in 2024
Yemen
11.0%
in 2024
Afghanistan rank
81st
Yemen rank
83rd
Antiretroviral therapy coverage for PMTCT over time
- Afghanistan
- Yemen
How they compare
Afghanistan currently reports 14.0% against 11.0% in Yemen, a difference of 3.0%.
That makes Afghanistan's figure about 1.3 times Yemen's.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Yemen ahead.
Afghanistan ranks 81st and Yemen ranks 83rd of 84 countries.
Across the 3 decades both report, Afghanistan averaged higher in 2 and Yemen in 1.
Head to head by decade
| Decade | Afghanistan | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3% | 0.7% | 0.4% | Yemen |
| 2010s | 9.0% | 4.0% | 5.0% | Afghanistan |
| 2020s | 21.4% | 8.8% | 12.6% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Afghanistan or Yemen?
- Afghanistan, at 14.0% against 11.0% in Yemen as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Afghanistan and Yemen?
- 3.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Yemen?
- 24 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Yemen rank globally for antiretroviral therapy coverage for pmtct?
- Afghanistan ranks 81st and Yemen ranks 83rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).